-
Epelsiban (INN, USAN, code name GSK-557,296-B) is an
orally bioavailable drug
which acts as a
selective and
potent oxytocin receptor antagonist (Ki =...
-
Retrieved 28 July 2014.
Borthwick AD,
Liddle J (January 2013). "Retosiban and
Epelsiban:
Potent and
Selective Orally available Oxytocin Antagonists". In Domling...
- Antagonists: Peptide:
Atosiban Tocinoic acid; Non-peptide:
Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662
Nolasiban Retosiban SSR-126768...
- Antagonists: Peptide:
Atosiban Tocinoic acid; Non-peptide:
Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662
Nolasiban Retosiban SSR-126768...
- Antagonists: Peptide:
Atosiban Tocinoic acid; Non-peptide:
Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662
Nolasiban Retosiban SSR-126768...
- Antagonists: Peptide:
Atosiban Tocinoic acid; Non-peptide:
Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662
Nolasiban Retosiban SSR-126768...
- Antagonists: Peptide:
Atosiban Tocinoic acid; Non-peptide:
Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662
Nolasiban Retosiban SSR-126768...
- non-selective over
vasopressin receptors Peptide Atosiban Barusiban Non-peptide
Epelsiban L-368,899 (CAS# 148927-60-0) L-371,257 (CAS# 162042-44-6) – peripherally...
- Antagonists: Peptide:
Atosiban Tocinoic acid; Non-peptide:
Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662
Nolasiban Retosiban SSR-126768...
- Antagonists: Peptide:
Atosiban Tocinoic acid; Non-peptide:
Barusiban Cligosiban Epelsiban Erlosiban IX-01 L-368,899 L-371,257 L-372,662
Nolasiban Retosiban SSR-126768...
